BioGaia AB (publ) (BIOG-B) - Total Assets

Latest as of June 2026: Skr1.34 Billion SEK ≈ $143.80 Million USD

Based on the latest financial reports, BioGaia AB (publ) (BIOG-B) holds total assets worth Skr1.34 Billion SEK (≈ $143.80 Million USD) as of June 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.

BioGaia AB (publ) - Total Assets Trend (2002–2025)

This chart illustrates how BioGaia AB (publ)'s total assets have evolved over time, based on quarterly financial data. Also see market cap of BioGaia AB (publ) for the company's overall valuation and market capitalisation.

BioGaia AB (publ) - Asset Composition Analysis

Current Asset Composition (December 2025)

BioGaia AB (publ)'s total assets of Skr1.34 Billion consist of 76.3% current assets and 23.7% non-current assets. Review BioGaia AB (publ) total liabilities to assess the company's total debt and financial obligations.

Asset Category	Amount (SEK)	% of Total Assets
Cash & Equivalents	Skr801.31 Million	50.2%
Accounts Receivable	Skr236.49 Million	14.8%
Inventory	Skr166.70 Million	10.4%
Property, Plant & Equipment	Skr181.15 Million	11.3%
Intangible Assets	Skr702.00K	0.0%
Goodwill	Skr146.50 Million	9.2%

Asset Composition Trend (2002–2025)

This chart illustrates how BioGaia AB (publ)'s asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. See current stock price of BioGaia AB (publ) for real-time trading data and today's change.

Show as percentage

Key Asset Composition Facts

Current vs. Non-Current Assets: BioGaia AB (publ)'s current assets represent 76.3% of total assets in 2025, a decrease from 79.9% in 2002.
Cash Position: Cash and equivalents constituted 50.2% of total assets in 2025, down from 74.6% in 2002.
Tangible vs. Intangible: Intangible assets (including goodwill) make up 9.0% of total assets, a decrease from 15.0% in 2002.
Asset Diversification: The largest asset category is cash and equivalents at 50.2% of total assets.

BioGaia AB (publ) Competitors by Total Assets

Key competitors of BioGaia AB (publ) based on total assets are shown below.

Company	Country	Total Assets
Swedish Orphan Biovitrum AB (publ) ST:SOBI	Sweden	Skr81.26 Billion
Yunnan Baiyao Group Co Ltd SHE:000538	China	CN¥53.34 Billion
Guangdong Zhongsheng Pharmaceutical Co Ltd SHE:002317	China	CN¥5.17 Billion
Takeda Pharmaceutical Co Ltd ADR NYSE:TAK	USA	$15.42 Trillion
Harbin Gloria Pharmaceuticals SHE:002437	China	CN¥3.14 Billion
Jiuzhitang Co Ltd SHE:000989	China	CN¥5.73 Billion
Renhe Pharmacy Co Ltd SHE:000650	China	CN¥7.93 Billion
Jiangsu Kanion Pharmaceutical Co Ltd SHG:600557	China	CN¥6.74 Billion

BioGaia AB (publ) - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric	Current	1 Year Ago	5 Years Ago
Current Ratio	4.44	5.74	16.75
Quick Ratio	4.44	5.74	16.75
Cash Ratio	0.00	3.45	14.70
Working Capital	Skr728.98 Million	Skr853.70 Million	Skr1.64 Billion

BioGaia AB (publ) - Advanced Valuation Insights

This section examines the relationship between BioGaia AB (publ)'s asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio	10.24
Latest Market Cap to Assets Ratio	0.73
Asset Growth Rate (YoY)	-21.4%
Total Assets	Skr1.60 Billion
Market Capitalization	$1.17 Billion USD

Valuation Analysis

Below Book Valuation: The market values BioGaia AB (publ)'s assets below their book value (0.73x), which may indicate investor concerns about asset quality or future growth.

Significant Asset Reduction: BioGaia AB (publ)'s assets decreased by 21.4% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.

Annual Total Assets for BioGaia AB (publ) (2002–2025)

The table below shows the annual total assets of BioGaia AB (publ) from 2002 to 2025.

Year	Total Assets	Change
2025-12-31	Skr1.60 Billion ≈ $171.95 Million	-21.45%
2024-12-31	Skr2.03 Billion ≈ $218.89 Million	-12.89%
2023-12-31	Skr2.33 Billion ≈ $251.27 Million	+5.46%
2022-12-31	Skr2.21 Billion ≈ $238.26 Million	+4.04%
2021-12-31	Skr2.13 Billion ≈ $229.01 Million	+11.23%
2020-12-31	Skr1.91 Billion ≈ $205.90 Million	+187.32%
2019-12-31	Skr665.90 Million ≈ $71.66 Million	+0.90%
2018-12-31	Skr659.97 Million ≈ $71.02 Million	+14.56%
2017-12-31	Skr576.11 Million ≈ $62.00 Million	+17.82%
2016-12-31	Skr488.98 Million ≈ $52.62 Million	+3.34%
2015-12-31	Skr473.18 Million ≈ $50.92 Million	+13.85%
2014-12-31	Skr415.61 Million ≈ $44.73 Million	+8.40%
2013-12-31	Skr383.42 Million ≈ $41.26 Million	-25.84%
2012-12-31	Skr517.02 Million ≈ $55.64 Million	+84.76%
2011-12-31	Skr279.83 Million ≈ $30.11 Million	+22.83%
2010-12-31	Skr227.82 Million ≈ $24.52 Million	+26.70%
2009-12-31	Skr179.81 Million ≈ $19.35 Million	+16.53%
2008-12-31	Skr154.31 Million ≈ $16.61 Million	+39.30%
2007-12-31	Skr110.77 Million ≈ $11.92 Million	+22.05%
2006-12-31	Skr90.76 Million ≈ $9.77 Million	+4.14%
2005-12-31	Skr87.15 Million ≈ $9.38 Million	-19.68%
2004-12-31	Skr108.51 Million ≈ $11.68 Million	-20.16%
2003-12-31	Skr135.90 Million ≈ $14.63 Million	-15.92%
2002-12-31	Skr161.63 Million ≈ $17.39 Million	--

About BioGaia AB (publ)

ST:BIOG-B Sweden Drug Manufacturers - Specialty & Generic

Market Cap

$1.17 Billion

Skr10.83 Billion SEK

Market Cap Rank

#8273 Global

#128 in Sweden

Share Price

Skr110.00

Change (1 day)

+1.76%

52-Week Range

Skr96.80 - Skr134.90

All Time High

Skr427.58